vs
Lifeway Foods, Inc.（LWAY）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Lifeway Foods, Inc.的1.3倍（$69.8M vs $55.4M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 4.6%，领先379.4%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 18.0%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 11.4%）
来福威食品公司是一家总部位于美国伊利诺伊州的健康食品企业，成立于1986年，是美国业内领先的开菲尔发酵益生菌产品供应商，这类产品主要用于调节人体微生物群平衡。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
LWAY vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.3倍
$55.4M
营收增速更快
RIGL
高出3.2%
18.0%
净利率更高
RIGL
高出379.4%
4.6%
两年增速更快
RIGL
近两年复合增速
11.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $55.4M | $69.8M |
| 净利润 | $2.5M | $268.1M |
| 毛利率 | 27.8% | 91.5% |
| 营业利润率 | 6.8% | 33.2% |
| 净利率 | 4.6% | 384.0% |
| 营收同比 | 18.0% | 21.2% |
| 净利润同比 | 1688.1% | 1769.2% |
| 每股收益（稀释后） | $0.15 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LWAYRIGL
| Q4 25 | $55.4M | $69.8M | ||
| Q3 25 | $57.1M | $69.5M | ||
| Q2 25 | $53.9M | $101.7M | ||
| Q1 25 | $46.1M | $53.3M | ||
| Q4 24 | $46.9M | $57.6M | ||
| Q3 24 | $46.1M | $55.3M | ||
| Q2 24 | $49.2M | $36.8M | ||
| Q1 24 | $44.6M | $29.5M |
净利润LWAYRIGL
| Q4 25 | $2.5M | $268.1M | ||
| Q3 25 | $3.5M | $27.9M | ||
| Q2 25 | $4.2M | $59.6M | ||
| Q1 25 | $3.5M | $11.4M | ||
| Q4 24 | $-160.0K | $14.3M | ||
| Q3 24 | $3.0M | $12.4M | ||
| Q2 24 | $3.8M | $-1.0M | ||
| Q1 24 | $2.4M | $-8.2M |
毛利率LWAYRIGL
| Q4 25 | 27.8% | 91.5% | ||
| Q3 25 | 28.7% | 93.2% | ||
| Q2 25 | 28.6% | 95.6% | ||
| Q1 25 | 23.9% | 91.7% | ||
| Q4 24 | 25.3% | 89.9% | ||
| Q3 24 | 25.7% | 85.5% | ||
| Q2 24 | 27.0% | 92.4% | ||
| Q1 24 | 25.8% | 93.1% |
营业利润率LWAYRIGL
| Q4 25 | 6.8% | 33.2% | ||
| Q3 25 | 8.8% | 40.9% | ||
| Q2 25 | 10.8% | 60.1% | ||
| Q1 25 | 3.4% | 23.9% | ||
| Q4 24 | 1.5% | 28.9% | ||
| Q3 24 | 9.1% | 25.4% | ||
| Q2 24 | 11.0% | 1.2% | ||
| Q1 24 | 8.0% | -23.6% |
净利率LWAYRIGL
| Q4 25 | 4.6% | 384.0% | ||
| Q3 25 | 6.2% | 40.2% | ||
| Q2 25 | 7.9% | 58.6% | ||
| Q1 25 | 7.7% | 21.5% | ||
| Q4 24 | -0.3% | 24.9% | ||
| Q3 24 | 6.5% | 22.5% | ||
| Q2 24 | 7.7% | -2.8% | ||
| Q1 24 | 5.4% | -27.9% |
每股收益（稀释后）LWAYRIGL
| Q4 25 | $0.15 | $14.11 | ||
| Q3 25 | $0.23 | $1.46 | ||
| Q2 25 | $0.28 | $3.28 | ||
| Q1 25 | $0.23 | $0.63 | ||
| Q4 24 | $0.00 | $0.82 | ||
| Q3 24 | $0.19 | $0.70 | ||
| Q2 24 | $0.25 | $-0.06 | ||
| Q1 24 | $0.16 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.6M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $85.8M | $391.5M |
| 总资产 | $105.6M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资LWAYRIGL
| Q4 25 | $5.6M | $155.0M | ||
| Q3 25 | $23.0M | $137.1M | ||
| Q2 25 | $21.2M | $108.4M | ||
| Q1 25 | $19.4M | $77.1M | ||
| Q4 24 | $16.7M | $77.3M | ||
| Q3 24 | $20.6M | $61.1M | ||
| Q2 24 | $14.6M | $49.1M | ||
| Q1 24 | $12.0M | $49.5M |
总债务LWAYRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | $2.5M | $60.0M |
股东权益LWAYRIGL
| Q4 25 | $85.8M | $391.5M | ||
| Q3 25 | $82.8M | $117.6M | ||
| Q2 25 | $78.7M | $81.9M | ||
| Q1 25 | $74.2M | $18.6M | ||
| Q4 24 | $71.9M | $3.3M | ||
| Q3 24 | $71.5M | $-14.6M | ||
| Q2 24 | $68.0M | $-29.9M | ||
| Q1 24 | $63.5M | $-31.7M |
总资产LWAYRIGL
| Q4 25 | $105.6M | $513.6M | ||
| Q3 25 | $109.5M | $242.5M | ||
| Q2 25 | $98.3M | $206.7M | ||
| Q1 25 | $93.7M | $176.0M | ||
| Q4 24 | $90.5M | $164.0M | ||
| Q3 24 | $91.3M | $139.4M | ||
| Q2 24 | $84.9M | $128.4M | ||
| Q1 24 | $82.8M | $126.5M |
负债/权益比LWAYRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.04× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $267.0K | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-17.4M | — |
| 自由现金流率自由现金流/营收 | -31.5% | — |
| 资本支出强度资本支出/营收 | 31.9% | — |
| 现金转化率经营现金流/净利润 | 0.11× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-16.4M | — |
8季度趋势，按日历期对齐
经营现金流LWAYRIGL
| Q4 25 | $267.0K | $22.0M | ||
| Q3 25 | $6.9M | $24.0M | ||
| Q2 25 | $3.9M | $30.5M | ||
| Q1 25 | $-150.0K | $-893.0K | ||
| Q4 24 | $-2.6M | $14.5M | ||
| Q3 24 | $7.5M | $21.7M | ||
| Q2 24 | $6.5M | $302.0K | ||
| Q1 24 | $1.5M | $-5.0M |
自由现金流LWAYRIGL
| Q4 25 | $-17.4M | — | ||
| Q3 25 | $1.8M | — | ||
| Q2 25 | $1.6M | — | ||
| Q1 25 | $-2.4M | — | ||
| Q4 24 | $-3.8M | — | ||
| Q3 24 | $5.9M | — | ||
| Q2 24 | $5.1M | — | ||
| Q1 24 | $-923.0K | — |
自由现金流率LWAYRIGL
| Q4 25 | -31.5% | — | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 3.0% | — | ||
| Q1 25 | -5.1% | — | ||
| Q4 24 | -8.2% | — | ||
| Q3 24 | 12.8% | — | ||
| Q2 24 | 10.4% | — | ||
| Q1 24 | -2.1% | — |
资本支出强度LWAYRIGL
| Q4 25 | 31.9% | — | ||
| Q3 25 | 9.0% | — | ||
| Q2 25 | 4.3% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 3.3% | — | ||
| Q2 24 | 2.9% | — | ||
| Q1 24 | 5.5% | — |
现金转化率LWAYRIGL
| Q4 25 | 0.11× | 0.08× | ||
| Q3 25 | 1.96× | 0.86× | ||
| Q2 25 | 0.92× | 0.51× | ||
| Q1 25 | -0.04× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 2.50× | 1.75× | ||
| Q2 24 | 1.73× | — | ||
| Q1 24 | 0.64× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LWAY
| Drinkable Kefirotherthan Pro Bugs | $47.8M | 86% |
| Cheese | $4.7M | 8% |
| Cream And Other | $1.7M | 3% |
| Other | $1.2M | 2% |
RIGL
暂无分部数据
